Author

Carly Selan

Monash University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Abbey WillcoxiD· 2 shared Harshal H. NandurkariD· 2 shared Ilaria Calvello· 2 shared Ioanna SavvidouiD· 2 shared Karlheinz PeteriD· 2 shared Maithili SashindranathiD· 2 shared Natasha Ting Lee· 2 shared Simon Christopher RobsoniD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Abbey WillcoxORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endothelial-targeted CD39 prevents Toxin-induced Pulmonary Hypertension Mice.

Abbey Willcox, Ioanna Savvidou, Natasha Ting Lee, Carly Selan, Ilaria Calvello, Simon Christopher Robson, Viktoria Bongcaron, Aidan P. G. Walsh, Yuyang Song, Xiaowei Wang, Trevor Williams, Karlheinz Peter, Harshal H. Nandurkar, Maithili Sashindranath

This paper shows that targeting CD39 on endothelial cells prevents toxin-induced pulmonary hypertension in mice by multiple mechanisms including adenosine signaling and reducing inflammation.

bioRxiv · Nov 5, 2025 · PreprintPhysiology

Development of endothelial-targeted CD39 as a therapy for ischaemic stroke

Natasha Ting Lee, Ioanna Savvidou, Carly Selan, Ilaria Calvello, Amy Vuong, David K. Wright, Robert Brkljača, Abbey Willcox, Joanne SJ Chia, Xiaowei Wang, Karlheinz Peter, Simon Christopher Robson, Robert Lindsay Medcalf, Harshal H. Nandurkar, Maithili Sashindranath

This paper develops an endothelial-targeted CD39 therapy for ischaemic stroke, showing reduced infarct size and improved BBB integrity when administered 3 hours post-ischaemia.

Journal of Thrombosis and Haemostasis · May 14, 2024Peer-reviewedNeuroscience